Core Viewpoint - The article highlights the increasing prevalence of academic misconduct in Chinese medical institutions, particularly involving the buying and selling of research data, which has led to significant concerns regarding the integrity of scientific research in the healthcare sector [1][2][3]. Group 1: Academic Misconduct Cases - The National Natural Science Foundation of China recently reported 21 cases of academic misconduct, with several involving the sale of experimental research data, primarily occurring in hospitals and medical schools [1]. - A notable case involved a urology department head at a prestigious hospital who was found to have engaged in data trading related to a study on prostate cancer cell proliferation [1]. - The foundation has established a reporting channel for academic misconduct, and there has been increased public awareness and scrutiny of "problematic papers" in hospitals [1]. Group 2: Issues in Research and Publication - A recent incident at Shandong University Qilu Hospital revealed a paper claiming to address "male uterine fibroid patients," which prompted an investigation and subsequent disciplinary action against the involved nurse [2]. - The journal "Chinese Medical Guidelines" acknowledged flaws in its review process that allowed for the publication of fraudulent papers, leading to the dismissal of an editor and the implementation of corrective measures [2]. - Experts attribute the rise of "paper mills" to the rigid evaluation standards and inadequate reward systems in hospitals, where some doctors resort to academic misconduct to meet publication demands [2][3]. Group 3: Quality of Research Output - Despite the high volume of papers published by Chinese doctors annually, the number of high-quality, impactful studies remains low, resulting in wasted national research funding [4]. - Some hospitals are beginning to incorporate public education as a performance metric, providing alternative pathways for career advancement beyond traditional publication metrics [4]. - The emergence of "popular science" doctors on social media platforms is seen as a double-edged sword, with some viewing it as a means to enhance public health awareness, while others criticize it as a distraction from clinical and research responsibilities [4]. Group 4: Institutional Perspectives - While some hospitals encourage doctors to engage in public education, emphasizing its potential benefits for both personal and institutional growth, others maintain that scientific research should remain the primary focus, with public outreach not substituting for academic publications [5].

Core Viewpoint - The article highlights the prevalence of academic misconduct in Chinese hospitals, particularly in the context of research papers, and discusses the shift towards valuing public education and outreach as part of the evaluation criteria for medical professionals [1][4]. Group 1: Academic Misconduct - The National Natural Science Foundation of China reported 21 cases of research misconduct, including data trading, primarily occurring in hospitals and medical schools [1][3]. - A notable case involved a urology department head at a prestigious hospital, whose paper on prostate cancer cell proliferation was flagged for data trading [1]. - The foundation has consistently addressed academic misconduct, with hospitals being significant sources of problematic papers [1][4]. Group 2: Institutional Responses - Shandong University Qilu Hospital responded to public complaints about a paper that incorrectly included male patients with uterine fibroids, leading to disciplinary actions against the involved nurse [3]. - The journal "Chinese Medical Guide" acknowledged flaws in its review process that allowed for the publication of fraudulent papers and has since taken corrective measures [3]. Group 3: Shift in Evaluation Criteria - Experts suggest that the rise of "paper factories" is linked to rigid evaluation standards in hospitals, where some doctors resort to misconduct to meet publication requirements [4]. - There is a growing trend among hospitals to incorporate public education as a metric for evaluating doctors, aiming to alleviate the "paper-only" assessment culture [1][4]. - Some hospitals are now promoting "science popularization" as a means for doctors to enhance their careers, which can also attract more patients [5]. Group 4: Public Engagement and Perception - The emergence of "science popularization" influencers among doctors is seen as a double-edged sword, with some viewing it as a way to improve public health awareness while others criticize it as a distraction from clinical and research responsibilities [5]. - Private hospitals are increasingly favoring "popular science" doctors for their ability to attract patient traffic, indicating a shift in hiring practices [5]. - However, some institutions maintain that traditional research output remains the primary focus, emphasizing the importance of publishing in recognized academic journals over social media platforms [5].

贵州赤天化股份有限公司 GUIZHOU CHITIANHUA CO.,LTD. 会议资料 二〇二五年六月 贵州赤天化股份有限公司 2025 年第二次临时股东大会会议资料 贵州赤天化股份有限公司 会议时间：2025 年 6 月 25 日 14:00 序号 会 议 议 程 审议《关于募投项目调整投资规模、结项并将节余募集资金永久补充流 动资金的议案》 贵州赤天化股份有限公司 2025 年第二次临时股东大会会议资料 议 案 关于募投项目调整投资规模、结项并将节余募集资金 永久补充流动资金的议案 各位股东、各位代表： 一、募集资金基本情况 会议地点：贵州省贵阳市阳关大道 28 号赤天化大厦 22 楼会议室 主 持 人：董事长丁林洪 经中国证券监督管理委员会《关于核准贵州赤天化股份有限公司向贵州渔阳 贸易有限公司发行股份购买资产并募集配套资金的批复》 （证监许可〔2016〕2005 号）核准，公司以非公开发行方式发行人民币普通股（A 股）327,787,021 股， 募集资金总额为人民币 1,969,999,996.21 元，扣除发行费等相关费用后，实际 募集资金净额为 1,943,799,996.25 元。上述资金于 ...

烟台毓璜顶医院 ··· ·· o E 卡余额提现 个人体征 住院业务 le E e a 住院须知 办理住院 住院预交 每日清单 El l 佳院待检 佳院报告 手术进度 出院结算 0 r 住院费用明细 出院带药 病案复印 体检服务 型 œ CD x 健康体检 检查预约 健康天地 体检须知 信息查询 2 国 A 111 赌场记录 个人中心 < 智能导诊 ··· | ⊙ 以上为历史对话 你好,我是Al健康助理,正在为你 提供导诊服务,你可以简单描述下 你的症状,比如咳嗽,发烧,流鼻 涕等 ® & B AI回答仅供参考(公测版) 最近睡眠不太好 您最近是入睡困难,还是夜间容易 醒来,或者是早上醒得太早呢? a B Al回答仅供参考(公测版) 1) 入睡困难 夜间易醒 早醒 19 关注健康,畅所欲言 ... � Ð 报告单 < 智能导诊 ·· ⊙ 根据您的描述,为您推荐以下科 室: 内分泌科:您近期的早醒可能与内 分泌失调有关,内分泌科可以评估 并治疗可能的激素水平异常。 中医科:中医科可以从整体调理的 角度,帮助改善您的睡眠质量。 神经内科:如果早醒伴随有焦虑、 抑郁等情绪问题,神经内科可以提 供进一步的评估和治疗。 ...

Core Viewpoint - The Huangshi Boshi Anorectal Hospital has been found to engage in excessive medical practices, with over 90% of patients undergoing surgery, significantly higher than the local average of 40% [3][4][8] Group 1: Investigation Findings - Out of 125 sampled cases, 113 were identified to have excessive medical behaviors, including surgeries performed on patients who did not meet surgical indications [3][4] - The hospital's overall surgical rate exceeds 90%, which is substantially higher than the local average of 40% [4] - The hospital has been penalized with a punitive compensation of over 530,000 yuan, three times the amount involved in the case [1] Group 2: Misleading Practices - The hospital utilized false advertising to attract patients, promoting low-cost diagnostic services that led to high overall treatment costs [4][5] - Patients were often misled about their medical conditions, with doctors exaggerating the severity to induce unnecessary surgeries [4][5] - There were instances of doctors changing to more expensive medical supplies during surgeries without patient consent, leading to inflated medical bills [5] Group 3: Systemic Issues - The Huangshi Boshi Anorectal Hospital, established in December 2015, operates as a private institution with a focus on maximizing revenue, linking departmental profits to staff salaries [6][7] - The hospital's past violations included multiple administrative penalties for fraudulent billing practices, yet it continued to operate without significant changes [8] - The lack of stringent penalties for excessive medical practices has allowed such behaviors to persist, with fines being minimal compared to the hospital's revenue from surgeries [8] Group 4: Recommendations for Improvement - There is a call for improved legal frameworks to address excessive medical practices, including clearer penalties for hospitals and doctors [9] - Enhanced collaboration between health, insurance, and law enforcement agencies is recommended to improve the detection and prosecution of excessive medical practices [9] - Patient education is crucial to empower individuals to question medical recommendations and retain evidence for potential legal recourse [10]

百万用户都在看 6月12日，甘肃白银平川区人民医院宣告6月14日停诊。 澎湃新闻从平川区政府获悉，该院成立于1986年，医院编制床位200张，全院共有在职职工359人。截至今年2 月，在编人员153人。 官方指出该院存在基础设施建设薄弱、运行状况逐年变差、编制不足、紧缺专业人才不足等问题，当地卫健部 门公告，停诊是为了优化医疗资源布局。 6月16日，该医院工作人员告诉澎湃新闻记者，停诊谋划已久，属于正常改革。医护将分流至其他医疗单位， 院内患者会完成医疗周期，"我们3天后19号搬家"。 来源：澎湃新闻 责编：汪云鹏 校对： 杨舒欣 违法和不良信息举报电话：0755-83514034 邮箱：bwb@stcn.com 暴增超370%！A股，重磅信号！ 深夜突发，闪崩！ 重大转变！美国下令：暂停！ 午后，突发！集体飙涨！ 李成钢：中美就落实两国元首通话共识及日内瓦会谈共识达成框架 ...

据通报，经核查，湘雅二医院根据绩效管理办法向肾脏移植科发放医务人员绩效，由科室根据 职工实际工作量进行二次分配。但该科室违反医院相关规定，存在将部分绩效先发放至多名研 究生账户，再转至个别职工账户的现象。 中南大学湘雅二医院研究生罗某宇坠亡后，家属称在其电脑发现可疑转账记录及医疗腐败相关 举报材料，引发社会高度关注。6月13日晚间，由湖南省卫生健康委、中南大学、长沙市公安 局组成的联合调查组发布情况通报，通报关于质疑涉事医院"通过罗某宇等研究生洗黑钱、分 赃款"的核查情况。 中南大学湘雅二医院。 更多财经视频，请关注视频号"新浪财经" 往期回顾 罗某宇近三年在读期间，科室累计向其发放33.379万元，其中29.526万元分批次转回科室原护 士长，用于发放科室人员绩效，剩余3.853万元为罗某宇个人绩效。该行为反映出该科室在绩效 分配中存在管理不规范问题，已责令医院整改，并对涉事科室主任、护士长等4人进行了严肃 问责。 来源：极目新闻 ...

官方通报。 2024年5月8日，中南大学湘雅二医院研究生罗某宇在租住小区坠楼身亡，公安机关第一时间介入调查，认定系 跳楼自杀身亡，排除刑事案件。2024年8月以来，罗某宇家属向湖南省卫健、公安等部门寄送举报材料，并通 过网络反映相关问题。相关部门高度重视，着手开展调查工作。2024年11月，湖南省卫生健康委、中南大学、 长沙市公安局组成联合调查组，针对反映的问题进行全面调查核查。现将有关情况通报如下。 一、事件经过及调查情况 2024年5月8日上午8时10分，长沙市公安局110指挥中心接群众报警称：在雨花区侯家塘街道地质家园小区1栋 楼下有一男子坠楼身亡。上午8时20分，雨花分局民警到达现场，开展调查访问、现场勘查等工作。经查，坠 亡男子为罗某宇，1996年3月生，四川内江人，湘雅二医院2021级外科学硕士研究生（肾脏移植方向），与3名 同学合租在该小区1栋。 （一）现场勘查情况 经尸表检验，死者罗某宇全颅崩裂、脑组织破碎、双侧肋骨广泛粉碎性骨折、右小腿开放性粉碎性骨折，结合 死者损伤的形态特征、分布特点及形成机制等，死者系高坠致严重颅脑损伤及全身多发损伤而死亡。经理化检 验，死者心血中未检出常见毒物及镇静、 ...

Core Viewpoint - The article highlights the journey of Tang Haiyu, a dedicated medical professional who has spent 19 years serving in the highest-altitude city in China, Naqu, Tibet, and her significant contributions to the local healthcare system [3][4][5]. Group 1: Personal Journey and Contributions - Tang Haiyu was one of the first volunteers in the Western Program, arriving in Naqu in 2003 and evolving from a fresh graduate to a trusted physician known as "Manba" among the local Tibetan population [3][4][5]. - Over her 19 years, she witnessed and contributed to the development of Naqu People's Hospital, which transformed from a facility that frequently referred patients to Lhasa to becoming a top-tier hospital capable of handling complex cases [3][4][19]. - Tang's work in the infectious disease department was crucial, especially in a region with high incidences of diseases like tuberculosis and hepatitis, where she faced significant challenges due to limited medical resources [9][10][18]. Group 2: Challenges and Achievements - The harsh living conditions in Naqu, including extreme weather and inadequate infrastructure, posed significant challenges for healthcare delivery, yet Tang adapted and thrived in this environment [4][8][21]. - The establishment of the infection control department and the hospital's elevation to a tertiary hospital status were pivotal achievements during her tenure, reflecting the improvements in local healthcare standards [13][18]. - Tang's efforts in training local staff and implementing advanced medical practices have led to a notable decrease in the incidence of infectious diseases in the region [12][18]. Group 3: Legacy and Future - Tang Haiyu's departure from Naqu to work as a school doctor in Lhasa marks a transition, but her influence continues as she trains the next generation of healthcare workers [26]. - The ongoing commitment of new volunteers to the Western Program indicates a sustained effort to improve healthcare in Tibet, with Tang serving as a role model for future medical professionals [25][26]. - The advancements in Naqu People's Hospital, including the establishment of a high-altitude medical research institute, signify a promising future for healthcare in the region [19][20].

Group 1 - The core objective of the study is to evaluate the clinical effectiveness of self-administered selatogrel in preventing all-cause mortality and treating acute myocardial infarction (AMI) in subjects with a recent history of AMI [1] - The study is a multicenter, randomized, double-blind, placebo-controlled trial, marking the first registered global clinical trial initiated by the cardiology department of Dongying People's Hospital [1] - The kickoff meeting included detailed discussions on the research background, study design, inclusion and exclusion criteria, efficacy and safety indicators, and drug administration protocols [1] Group 2 - The successful convening of the kickoff meeting highlights the clinical research capabilities of Dongying People's Hospital in the field of cardiovascular diseases [2] - The hospital's drug clinical trial institution aims to maintain a scientific and rigorous approach, deepen domestic and international research cooperation, and promote the standardization of clinical research [2] - This initiative is expected to enhance the hospital's overall strength and influence in the cardiovascular discipline [2]